75F40119D1001975F40120F19009 and task orders 05, for FY21 cber RE-block and stack

Ended Awarded Last action

Contract number
75F40121F19009
Awardee
Awarding agency
Obligated
$361,779

Award facts

Contract value 100% obligated
$361,779.16 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Competitive 8(a)
Competition
Full and Open Competition after exclusion of sources Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Lanham, MD 20706, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00001 · The purpose of this modification is to DE-obligate funds and close out the contract. -$23,906
Original award $385,685

About this award

This modification closes out a $361,779 firm fixed-price delivery order (75F40119D1001975F40120F19009) issued under the Food and Drug Administration's larger $50 million 8(a) set-aside indefinite delivery/indefinite quantity (IDIQ) contract. The award to Elocen Global Technology, LLC, a minority-owned, small disadvantaged, woman-owned, and service-disabled veteran-owned business based in Lanham, Maryland, represents de-obligation and contract closeout activities related to FY21 CBER re-block and stack operations. The modification, effective through the ultimate completion date of September 29, 2024, addresses work performed under Task Order 05.

Elocen Global Technology has maintained a consistent relationship with the FDA as prime contractor, delivering services spanning warehouse management, move management, document shredding, program and project management, and IT infrastructure support at FDA facilities in the Lanham and White Oak, Maryland areas. The company has executed multiple delivery orders under its 8(a) set-aside vehicle without utilizing subcontractors, with individual contract values ranging from under $100,000 to over $2.6 million. This closeout modification reflects the conclusion of specific task order work and represents standard contract administration activities as the company's FDA engagement extends through 2024–2025.

Quick answers

Who was awarded contract 75F40121F19009?

75F40121F19009 was awarded to Elocen Global Technology, LLC by Food and Drug Administration (Department of Health and Human Services) on March 8, 2021.

How much is contract 75F40121F19009 worth?

The government has obligated $361,779 on 75F40121F19009.

Is contract 75F40121F19009 an order under another contract?

Yes. 75F40121F19009 is a delivery order under 75F40119D10019, an indefinite delivery contract.

Was contract 75F40121F19009 competed?

The extent of competition for 75F40121F19009 was full and open competition after exclusion of sources. It was set aside: Competitive 8(a).

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award